A 1-Month, Prospective, Multicenter, Open-Label Study of OTO-201 Given as a Single Administration for Treatment of Otitis Externa
Latest Information Update: 21 Oct 2020
At a glance
- Drugs Ciprofloxacin (Primary)
- Indications Otitis externa
- Focus Adverse reactions; Therapeutic Use
- Sponsors Otonomy [CEASED]
- 03 Nov 2016 According to an Otonomy media release, results from this study were presented at the American Academy of Otolaryngology-Head and Neck Surgery Foundation (AAO-HNSF) 2016.
- 13 Sep 2016 According to an Otonomy media release, data from this study will be presented at the American Academy of Otolaryngology-Head and Neck Surgery Foundation (AAO-HNSF) 2016.
- 22 Jan 2016 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov.